1.A Case of Primary Malignant Lymphoma of Trachea.
Hyung Woo KIM ; Hui Kyoung SUN ; Seong Lim JIN ; Joon Hee KIM ; Ho Kee YUM ; Re Hwe KIM
Tuberculosis and Respiratory Diseases 1998;45(5):1067-1072
Primary malignant tumor of trachea is rare and often extensive at presentation and frequently causes life threatening airway obstruction. Primary extranodal lymphomas comprise about 10% of all malignant lymphomas. However, the primary malignant lymphoma of trachea is extremely rare. We presented here a case of 62-year-old male, was diagnosed as a primary extranodal lymphoma arising in the trachea with review of literature.
Airway Obstruction
;
Humans
;
Lymphoma*
;
Male
;
Middle Aged
;
Trachea*
2.A Case of Avascular Necrosis of Bone as the Initial Manifestation of Polyarteritis Nodosa.
Soo Min KIM ; Bo Hyung PARK ; Yu Jin KANG ; Mi Hui PARK ; Ju Kyoung SONG
The Journal of the Korean Rheumatism Association 2009;16(3):232-237
We describe a 28-year old man in otherwise apparently good health, in whom pain in his left knee joint caused by avascular necrosis led to a diagnosis of polyarteritis nodosa (PAN). The angiogram showed multiple microaneurysmal and thrombotic lesions, notably in the renal, mesenteric and tibial arteries. A skin biopsy of the upper dermis of the left thigh with an erythematous skin rash showed the infiltration of mononuclear leukocytes in the perivascular area. During hospitalization, he was diagnosed with chronic hepatitis B, and was treated with lamivudine, and corticosteroid, azathioprine to control the PAN. The knee joint pain improved progressively, and the patient could walk normally after several months. This case is an unusual presentation because the initial manifestation of PAN was avascular necrosis.
Azathioprine
;
Biopsy
;
Dermis
;
Exanthema
;
Hepatitis B, Chronic
;
Hospitalization
;
Humans
;
Knee Joint
;
Lamivudine
;
Leukocytes, Mononuclear
;
Necrosis
;
Osteonecrosis
;
Polyarteritis Nodosa
;
Skin
;
Thigh
;
Tibial Arteries
3.A Case of Pneumatosis Intestinalis Associated with Sunitinib Treatment for Renal Cell Carcinoma.
Yoo A CHOI ; Eun Hui SIM ; Kyoung Eun LEE ; Sun Young KO ; Min Ji SEO ; Young Jun YANG ; Ji Chan PARK ; Suk Young PARK
The Korean Journal of Gastroenterology 2013;61(6):347-350
Sunitinib as a multitarget tyrosine kinase inhibitor is one of the anti-tumor agents, approved by the United States Food and Drug Administration to use treat gastrointestinal stromal tumor and metastatic renal cell carcinoma. The agent is known to commonly induce adverse reactions such as fatigue, nausea, diarrhea, stomatitis, esophagitis, hypertension, skin toxicity, reduciton in cardiac output of left ventricle, and hypothyroidism. However, it has been reported to rarely induce adverse reactions such as nephrotic syndrome and irreversible reduction in renal functions, and cases of intestinal perforation or pneumatosis interstinalis as such reactions have been consistently reported. In this report, a 66-year old man showing abdominal pain had renal cell carcinoma and history of sunitinib at a dosage of 50 mg/day on a 4-weeks-on, 2-weeks-off schedule. Seven days after the third cycle he was referred to the hospital because of abdominal pain. Computed tomography showed pneumoperitoneum with linear pneumatosis intestinalis in his small bowel. The patient underwent surgical exploration that confirmed the pneumatosis intestinalis at 100 cm distal to Treitz's ligament. We report a rare case of intestinal perforation with pneumatosis intestinalis after administration of sunitinib to a patient with metastatic renal cell carcinoma.
Aged
;
Antineoplastic Agents/adverse effects/*therapeutic use
;
Carcinoma, Renal Cell/*drug therapy
;
Drug Administration Schedule
;
Humans
;
Indoles/adverse effects/*therapeutic use
;
Intestinal Perforation/*diagnosis/etiology/surgery
;
Kidney Neoplasms/*drug therapy
;
Lung/radiography
;
Male
;
Pneumatosis Cystoides Intestinalis/*diagnosis/etiology
;
Positron-Emission Tomography
;
Pyrroles/adverse effects/*therapeutic use
;
Tomography, X-Ray Computed
4.Anti-Helicobacter pylori effects of IgY from egg york of immunized hens.
Yun Hui YANG ; Dongsun PARK ; Goeun YANG ; Sun Hee LEE ; Dae Kwon BAE ; Jangbeen KYUNG ; Dajeong KIM ; Ehn Kyoung CHOI ; Jae Cheol SON ; Seock Yeon HWANG ; Yun Bae KIM
Laboratory Animal Research 2012;28(1):55-60
Effects of egg york containing IgY specific for Helicobacter pylori on the bacterial growth and intragastric infection were investigated in comparison with a proton-pump inhibitor pantoprazole. For in vitro anti-bacterial activity test, H. pylori (1x108 CFU/mL) was incubated with a serially diluted IgY for 3 days. As a result, IgY fully inhibited the bacterial growth at 16 mg/mL, which was determined to a minimal inhibitory concentration. In vivo elimination study, male C57BL/6 mice were infected with the bacteria by intragastric inoculation (1x108 CFU/mouse) 3 times at 2-day intervals, and 2 weeks later, orally treated twice a day with 50, 100, 200 or 500 mg/kg IgY for 18 days. After the final administration, biopsy sample of the gastric mucosa was assayed for the bacterial identification via urease, oxidase, catalase, nitrate reduction and H2S tests in addition to microscopic examination for mucosal inflammation. In CLO kit test, 75, 50, 12.5 and 12.5% of the animals revealed positive reaction following treatment with 50, 100, 200 and 500 mg/kg IgY, respectively, resulting in a superior efficacy at 200 mg/kg than 30 mg/kg pantoprazole that displayed 75% elimination. The CLO test results were confirmed by bacterial identification. Microscopic examination revealed that H. pylori infection caused severe gastric mucosal inflammation, which were not observed in the CLO-negative mice following treatment with IgY or pantoprazole. Taken together, IgY inhibited the growth of H. pylori, and improved gastritis and villi injuries by eliminating the bacteria from the stomach. The results indicate that IgY could be a good candidate overcoming tolerance of antibiotics for the treatment of H. pylori-mediated gastric ulcers.
2-Pyridinylmethylsulfinylbenzimidazoles
;
Animals
;
Anti-Bacterial Agents
;
Bacteria
;
Biopsy
;
Catalase
;
Gastric Mucosa
;
Gastritis
;
Helicobacter pylori
;
Humans
;
Immunoglobulins
;
Inflammation
;
Male
;
Mice
;
Ovum
;
Oxidoreductases
;
Stomach
;
Stomach Ulcer
;
Urease
5.The Impact of Chronic Cigarette Smoking on Arterial Stiffness in Korea.
Jong Bum KIM ; Won Yu KANG ; Seung Ju KIM ; Myoung Ju HONG ; Chan Young PARK ; Hyoung Min NO ; Kyoung Hui HONG ; Sun Ho HWANG ; Wan KIM
Journal of the Korean Geriatrics Society 2011;15(1):47-52
BACKGROUND: Cigarette smoking is an important modifiable cardiovascular risk factor, which is known to acutely increase arterial stiffness. But the chronic effects of smoking on arterial stiffness are still controvertial. We studied the effects of chronic cigarette smoking on arterial stiffness in Korean subjects. METHODS: Our subjects included those >18 years of age (n=2685, 991 females) who had undergone a pulse wave velocity from July 2004 to June 2008. They were classified into two groups, smokers (n=641) and non-smokers (n=2044). In addition to the pulse wave velocity (PWV), we reviewed the highly sensitive C-reactive protein levels in a random manner when it was available. RESULTS: Males were predominant in the smokers group. Smokers had significantly higher heart-femoral PWVs than non-smokers (1083.6+/-264.1 cm/sec vs. 1041.3+/-257.3 cm/sec; p<0.001). There was no linear relationship between smoking duration and PWV (r= -0.225, p=0.506) even after adjusting for age, sex, and body mass index. Furthermore, there was no difference in the ankle-brachial index between the two groups. On the multivariate regression analysis, age, male gender, hypertension, and diabetes were independent predictors of increased arterial stiffness. CONCLUSION: In this study, chronic cigarette smoking increased central arterial stiffness in Korean subjects.
Ankle Brachial Index
;
Body Mass Index
;
C-Reactive Protein
;
Humans
;
Hypertension
;
Korea
;
Male
;
Pulse Wave Analysis
;
Risk Factors
;
Smoke
;
Smoking
;
Tobacco Products
;
Vascular Stiffness
6.Phosphodiesterase Inhibitor Improves Renal Tubulointerstitial Hypoxia of the Diabetic Rat Kidney.
Hui Kyoung SUN ; Yun Mi LEE ; Kum Hyun HAN ; Han Seong KIM ; Seon Ho AHN ; Sang Youb HAN
The Korean Journal of Internal Medicine 2012;27(2):163-170
BACKGROUND/AIMS: Renal hypoxia is involved in the pathogenesis of diabetic nephropathy. Pentoxifyllin (PTX), a nonselective phosphodiesterase inhibitor, is used to attenuate peripheral vascular diseases. To determine whether PTX can improve renal hypoxia, we investigated its effect in the streptozocin (STZ)-induced diabetic kidney. METHODS: PTX (40 mg/kg, PO) was administered to STZ-induced diabetic rats for 8 weeks. To determine tissue hypoxia, we examined hypoxic inducible factor-1alpha (HIF-1alpha), heme oxygenase-1 (HO-1), vascular endothelial growth factor (VEGF), and glucose transporter-1 (GLUT-1) levels. We also tested the effect of PTX on HIF-1alpha in renal tubule cells. RESULTS: PTX reduced the increased protein creatinine ratio in diabetic rats at 8 weeks. HIF-1alpha, VEGF, and GLUT-1 mRNA expression increased significantly, and the expression of HO-1 also tended to increase in diabetic rats. PTX significantly decreased mRNA expression of HIF-1alpha and VEGF at 4 and 8 weeks, and decreased HO-1 and GLUT-1 at 4 weeks. The expression of HIF-1alpha protein was significantly increased at 4 and 8 weeks in tubules in the diabetic rat kidney. PTX tended to decrease HIF-1alpha protein expression at 8 weeks. To examine whether PTX had a direct effect on renal tubules, normal rat kidney cells were stimulated with CoCl2 (100 microM), which enhanced HIF-1alpha mRNA and protein levels under low glucose conditions (5.5 mM). Their expressions were similar even after high glucose (30 mM) treatment. PTX had no effect on HIF-1alpha expression. CONCLUSIONS: PTX attenuates tubular hypoxia in the diabetic kidney.
Animals
;
Anoxia/*drug therapy/enzymology/etiology/genetics
;
Cell Line
;
Cobalt/pharmacology
;
Diabetes Mellitus, Experimental/*complications
;
Diabetic Nephropathies/*drug therapy/enzymology/etiology/genetics
;
Disease Models, Animal
;
Gene Expression Regulation/drug effects
;
Glucose/metabolism
;
Glucose Transporter Type 1/genetics
;
Heme Oxygenase (Decyclizing)/genetics/metabolism
;
Hypoxia-Inducible Factor 1, alpha Subunit/genetics/metabolism
;
Kidney Tubules/*drug effects/enzymology
;
Male
;
Pentoxifylline/*pharmacology
;
Phosphodiesterase Inhibitors/*pharmacology
;
RNA, Messenger/metabolism
;
Rats
;
Rats, Sprague-Dawley
;
Streptozocin
;
Time Factors
;
Vascular Endothelial Growth Factor A/genetics
7.A Case of Adult Intussusception Induced by Intestinal Tuberculosis.
Hye Sun KANG ; Ji Young KANG ; Hyeon Hui KANG ; Hyun Jin KIM ; Keun Joon LIM ; Seung Kyoung KIM ; Sang Haak LEE ; Hwa Sik MOON ; Jong Kyung PARK
Tuberculosis and Respiratory Diseases 2010;69(3):196-200
Intussusception primarily occurs in children and is uncommon in adults. Moreover, intussusception caused by intestinal tuberculosis is very rare. We report a case of intussusception induced by intestinal tuberculosis. A 53-year-old man presented to our hospital with complaints of cough and sputum for 2 weeks. We started anti-tuberculosis medication as the patient's sputum acid-fast staining was positive. After 4 days of treatment, the patient developed abdominal cramping pain. Imaging studies showed ileo-ileal type intussusception. The patient underwent segmental resection of the small bowel and intestinal tuberculosis was confirmed on histological examination. He recovered after surgery and was discharged on anti-tuberculosis medication.
Adult
;
Child
;
Colic
;
Cough
;
Humans
;
Intussusception
;
Middle Aged
;
Sputum
;
Tuberculosis
;
Tuberculosis, Gastrointestinal
8.A Case of Adult Intussusception Induced by Intestinal Tuberculosis.
Hye Sun KANG ; Ji Young KANG ; Hyeon Hui KANG ; Hyun Jin KIM ; Keun Joon LIM ; Seung Kyoung KIM ; Sang Haak LEE ; Hwa Sik MOON ; Jong Kyung PARK
Tuberculosis and Respiratory Diseases 2010;69(3):196-200
Intussusception primarily occurs in children and is uncommon in adults. Moreover, intussusception caused by intestinal tuberculosis is very rare. We report a case of intussusception induced by intestinal tuberculosis. A 53-year-old man presented to our hospital with complaints of cough and sputum for 2 weeks. We started anti-tuberculosis medication as the patient's sputum acid-fast staining was positive. After 4 days of treatment, the patient developed abdominal cramping pain. Imaging studies showed ileo-ileal type intussusception. The patient underwent segmental resection of the small bowel and intestinal tuberculosis was confirmed on histological examination. He recovered after surgery and was discharged on anti-tuberculosis medication.
Adult
;
Child
;
Colic
;
Cough
;
Humans
;
Intussusception
;
Middle Aged
;
Sputum
;
Tuberculosis
;
Tuberculosis, Gastrointestinal
9.A Case of Churg-Strauss Syndrome Affecting Lung and Neuromuscular System.
Hyun Ju SONG ; Ju Hyun CHA ; Jin Hwa LEE ; Ji A LEE ; Sun Hui SUNG ; Hea Soo KOO ; You Kyoung KIM ; Jung Hyun CHANG
Tuberculosis and Respiratory Diseases 2002;53(2):183-189
Churg-Strauss syndrome(CSS) is a systemic vascular disorder that has an unknown cause with multiorgan involvement and diverse presentations. The three main histologically distinct phases were necrotizing vasculitis, tissue eosinophilia and extravascular granulomas. A diagnosis of CSS can be made on four or more of the following six criteria : 1) asthma, 2) peripheral eosinophilia >10% on the differential leukocyte count, 3) mononeuropathy (including multiple) or polyneuropathy, 4) paranasal sinus abnormalities, 5) nonfixed pulmonary infiltrates, and 6) biopsy evidence of extravascular eosinophils in the skin, the nerves, or the lungs. CSS has a good prognosis with systemic steroid therapy. The 5 year survival is approximately 70 %. We experienced a 66-year-old man who presented with cough, sputum, edema and numbness in both legs. He presented with all of the 6 CSS criteria. A nerve and muscle biopsy confirmed the diagnosis. Here, we report this case with a review of the relevant literatures.
Male
;
Humans
;
Biopsy
10.A Case of Churg-Strauss Syndrome Affecting Lung and Neuromuscular System.
Hyun Ju SONG ; Ju Hyun CHA ; Jin Hwa LEE ; Ji A LEE ; Sun Hui SUNG ; Hea Soo KOO ; You Kyoung KIM ; Jung Hyun CHANG
Tuberculosis and Respiratory Diseases 2002;53(2):183-189
Churg-Strauss syndrome(CSS) is a systemic vascular disorder that has an unknown cause with multiorgan involvement and diverse presentations. The three main histologically distinct phases were necrotizing vasculitis, tissue eosinophilia and extravascular granulomas. A diagnosis of CSS can be made on four or more of the following six criteria : 1) asthma, 2) peripheral eosinophilia >10% on the differential leukocyte count, 3) mononeuropathy (including multiple) or polyneuropathy, 4) paranasal sinus abnormalities, 5) nonfixed pulmonary infiltrates, and 6) biopsy evidence of extravascular eosinophils in the skin, the nerves, or the lungs. CSS has a good prognosis with systemic steroid therapy. The 5 year survival is approximately 70 %. We experienced a 66-year-old man who presented with cough, sputum, edema and numbness in both legs. He presented with all of the 6 CSS criteria. A nerve and muscle biopsy confirmed the diagnosis. Here, we report this case with a review of the relevant literatures.
Male
;
Humans
;
Biopsy